ReviewCureus2025
Effect of Vitamin D Supplementation on Blood Pressure: A Systematic Review.
Review in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hypertension is a major risk factor for cardiovascular disease and mortality. Emerging evidence suggests a potential role of vitamin D in blood pressure regulation through its influence on the renin-angiotensin-aldosterone system, endothelial function, and inflammation. However, findings from interventional studies remain inconsistent. This systematic review aims to evaluate the effect of vitamin D supplementation on systolic and diastolic blood pressure across various populations. A comprehensive literature search was conducted in PubMed, Cochrane Central, and ScienceDirect to identify randomized controlled trials and cohort studies investigating the impact of vitamin D on hypertension. Data extraction and risk of bias assessments were performed independently by two reviewers. The primary outcome was the change in systolic and diastolic blood pressure before and after vitamin D supplementation. In total, 12 studies met the inclusion criteria, with sample sizes ranging from 35 to 3,788 participants. The highest reduction in systolic blood pressure (-28.44 mmHg) and diastolic blood pressure (-7.38 mmHg) was observed in one study with 50,000 IU/week supplementation. Other studies reported reductions ranging from -0.5 to -4.5 mmHg for systolic blood pressure and -1 to -5 mmHg for diastolic blood pressure, with variability influenced by dosage and duration. Vitamin D supplementation demonstrates potential benefits in reducing blood pressure, particularly with higher doses over shorter durations. However, heterogeneity across studies warrants further research to establish optimal dosing strategies for hypertensive patients.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.